The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Vaccines: the Fourth Century
Open accessAbstract
Vaccine development, which began with Edward Jenner's observations in the late 18th century, has entered its 4th century. From its beginnings, with the use of whole organisms that had been weakened or inactivated, to the modern-day use of genetic engineering, it has taken advantage of the tools discovered in other branches of microbiology. Numerous successful vaccines are in use, but the list of diseases for which vaccines do not exist is long. However, the multiplicity of strategies now available, discussed in this article, portends even more successful development of vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 1×
“cerning the value of this strategy in vaccinology (115, 124).”
BackgroundBowman, P. W. (1963) · AIBS Bulletin · doi:10.2307/1292957 · Cited by 3,638
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829 · cited 1×
“These tools may enable us to make more use of cellular immune responses in addition to the antibody responses that are key to the success of almost all of the vaccines now in use (92).”
Self-citationLive Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
Belshe, R. B., Edwards, K. M., Vesikari, T., Black, S. V., Walker, R. E., Hultquist, M., Kemble, G., & Connor, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065368 · Cited by 811
HEK293 cell line: A vehicle for the expression of recombinant proteins
Thomas, P., & Smart, T. G. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2004.08.014 · Cited by 771
A universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Virus attenuation by genome-scale changes in codon pair bias
Coleman, J. R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., & Mueller, S. (2008) · Science · doi:10.1126/science.1155761 · Cited by 715 · cited 1×
“Other strategies include codon deoptimization (13, 20, 21, 23, 83, 99), which attenuates by changing the original nucleotide triplets preferred by the virus to code for amino acids to triplets less often used to code for the same amino acids; enhancement of replication fidelity of error-prone FIG.”
MethodRappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 704
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Crough, T., & Khanna, R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-08 · Cited by 644
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
New horizons in adjuvants for vaccine development
Reed, S. G., Bertholet, S., Coler, R. N., & Friede, M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.09.006 · Cited by 618
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
Maione, D., Margarit, I., Rinaudo, C. D., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E. T., Rosini, R., et al. (2005) · Science · doi:10.1126/science.1109869 · Cited by 556
New horizons in adjuvants for vaccine development
Reed, S. G., Tomai, M., & Gale, M. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.08.008 · Cited by 554
DNA Vaccines: Progress and Challenges
Donnelly, J. J., Wahren, B., & Liu, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.633 · Cited by 448
Huleatt, J. W., Nakaar, V., Desai, P., Huang, Y., Hewitt, D., Jacobs, A., Tang, J., McDonald, W., Song, L., Evans, R. K., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.10.062 · Cited by 382
Mueller, S., Papamichail, D., Coleman, J. R., Skiena, S., & Wimmer, E. (2006) · Journal of Virology · doi:10.1128/jvi.00738-06 · Cited by 382
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
The coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · bchm · doi:10.1515/bc.2008.064 · Cited by 369
Broers, A. E. C., van der Holt, R., van Esser, J. W. J., Gratama, J.-W., Henzen-Logmans, S., Kuenen-Boumeester, V., Löwenberg, B., & Cornelissen, J. J. (2000) · Blood · doi:10.1182/blood.v95.7.2240 · Cited by 348
An Evaluation of Measures of Synonymous Codon Usage Bias
Comeron, J. M., & Aguadé, M. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006384 · Cited by 337
Van Damme, P., Oosterhuis-Kafeja, F., Van der Wielen, M., Almagor, Y., Sharon, O., & Levin, Y. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.10.077 · Cited by 331
Johnson, P. R., Schnepp, B. C., Zhang, J., Connell, M. J., Greene, S. M., Yuste, E., Desrosiers, R. C., & Reed Clark, K. (2009) · Nature Medicine · doi:10.1038/nm.1967 · Cited by 310
Harari, A., Bart, P.-A., Stöhr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., Burnet, S., Cellerai, C., Erlwein, O., Barber, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071331 · Cited by 300
Colugnati, F. A., Staras, S. A., Dollard, S. C., & Cannon, M. J. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-71 · Cited by 298
Engineering attenuated virus vaccines by controlling replication fidelity
Vignuzzi, M., Wendt, E., & Andino, R. (2008) · Nature Medicine · doi:10.1038/nm1726 · Cited by 282
Cytomegalovirus Infections Following Renal Transplantation
Glenn, J. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.6.1151 · Cited by 265
Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
Nicolas, J.-F., & Guy, B. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1201 · Cited by 259
Burns, C. C., Shaw, J., Campagnoli, R., Jorba, J., Vincent, A., Quay, J., & Kew, O. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3259-3272.2006 · Cited by 259
Steel, J., Lowen, A. C., Pena, L., Angel, M., Solórzano, A., Albrecht, R., Perez, D. R., García-Sastre, A., & Palese, P. (2009) · Journal of Virology · doi:10.1128/jvi.01920-08 · Cited by 258
Holland, D., Booy, R., Looze, F. D., Eizenberg, P., McDonald, J., Karrasch, J., McKeirnan, M., Salem, H., Mills, G., Reid, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590434 · Cited by 254 · cited 1×
“The microneedle system has been applied to administration of influenza vaccine, for which equivalence or even superiority has been demonstrated in comparison with intramuscular injection (6, 52, 66, 117).”
Method(2005) · CRC Press eBooks · doi:10.1201/9780849359033 · Cited by 233
A short history of vaccination
Plotkin, S. L., & Plotkin, S. A. (2013) · Vaccines · doi:10.1016/b978-1-4557-0090-5.00017-3 · Cited by 222
Self-citationMonath, T. P., Guirakhoo, F., Nichols, R., Yoksan, S., Schrader, R., Murphy, C., Blum, P., Woodward, S., McCarthy, K., Mathis, D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/378356 · Cited by 218
Engineering microRNA responsiveness to decrease virus pathogenicity
Kelly, E. J., Hadac, E. M., Greiner, S., & Russell, S. J. (2008) · Nature Medicine · doi:10.1038/nm.1776 · Cited by 217
Mast cell activators: a new class of highly effective vaccine adjuvants
McLachlan, J. B., Shelburne, C. P., Hart, J. P., Pizzo, S. V., Goyal, R., Brooking-Dixon, R., Staats, H. F., & Abraham, S. N. (2008) · Nature Medicine · doi:10.1038/nm1757 · Cited by 206
Luckay, A., Sidhu, M. K., Kjeken, R., Megati, S., Chong, S.-Y., Roopchand, V., Garcia-Hand, D., Abdullah, R., Braun, R., Montefiori, D. C., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00055-07 · Cited by 203
Stahl-Hennig, C., Eisenblätter, M., Jasny, E., Rzehak, T., Tenner-Racz, K., Trumpfheller, C., Salazar, A. M., Überla, K., Nieto, K., Kleinschmidt, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000373 · Cited by 198
Guirakhoo, F., Kitchener, S., Morrison, D., Forrat, R., McCarthy, K., Nichols, R., Yoksan, S., Duan, X., Ermak, T. H., Kanesa-Thasan, N., et al. (2006) · Human Vaccines · doi:10.4161/hv.2.2.2555 · Cited by 197
Heiny, A. T., Miotto, O., Srinivasan, K. N., Khan, A. M., Zhang, G. L., Brusic, V., Tan, T. W., & August, J. T. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001190 · Cited by 196
FluBlok, a next generation influenza vaccine manufactured in insect cells
Cox, M. M. J., & Hollister, J. R. (2009) · Biologicals · doi:10.1016/j.biologicals.2009.02.014 · Cited by 194
Markowitz, L. E., & Schiller, J. T. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa621 · Cited by 168
Hirao, L. A., Wu, L., Khan, A. S., Satishchandran, A., Draghia-Akli, R., & Weiner, D. B. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.10.041 · Cited by 167
Barnes, D., Kunitomi, M., Vignuzzi, M., Saksela, K., & Andino, R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.003 · Cited by 166
A decade after the generation of a negative-sense RNA virus from cloned cDNA – what have we learned?
Neumann, G., Whitt, M. A., & Kawaoka, Y. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-11-2635 · Cited by 165
Verstraeten, T., Descamps, D., David, M., Zahaf, T., Hardt, K., Izurieta, P., Dubin, G. O., & Breuer, T. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.049 · Cited by 155
Berencsi, K., Gyulai, Z., Gönczöl, É., Pincus, S. E., Cox, W. I., Michelson, S., Kari, L., Méric, C., Cadoz, M., Zahradnik, J. M., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/319680 · Cited by 146
Self-citationNanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 143
Immunology of TLR-independent vaccine adjuvants
Gregorio, E. D., D’Oro, U., & Wack, A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.003 · Cited by 127
McKenzie, R., Bourgeois, A. L., Frech, S. A., Flyer, D. C., Bloom, A., Kazempour, K., & Glenn, G. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.043 · Cited by 127
Trivalent MDCK cell culture-derived influenza vaccine Optaflu®(Novartis Vaccines)
Doroshenko, A., & Halperin, S. A. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.31 · Cited by 126
Laddy, D. J., Yan, J., Khan, A. S., Andersen, H., Cohn, A. C., Greenhouse, J. J., Lewis, M. G., Manischewitz, J. F., King, L. R., Golding, H., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02335-08 · Cited by 126
Leroux‐Roels, I., Vets, E., Freese, R., Seiberling, M., Weber, F., Salamand, C., & Leroux-Roels, G. G. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.078 · Cited by 121
Hassett, D. E., Zhang, J., & Whitton, J. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7881-7888.1997 · Cited by 115
Belshe, R. B., Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., & Frey, S. E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.066 · Cited by 107
Haynes, J. R., Dokken, L., Wiley, J. A., Cawthon, A. G., Bigger, J. E., Harmsen, A. G., & Richardson, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.011 · Cited by 103
An avian cell line designed for production of highly attenuated viruses
Jordan, I., Vos, A. C., Beilfuß, S., Neubert, A., Breul, S., & Sandig, V. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.066 · Cited by 102
Therapeutic and prophylactic applications of alphavirus vectors
Atkins, G. J., Fleeton, M. N., & Sheahan, B. J. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000859 · Cited by 100
Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy
Barry, M. A., & Cooper, C. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.11.1731 · Cited by 93
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
Schmidt, A. C., Wenzke, D. R., McAuliffe, J. M., Claire, M. S., Elkins, W. R., Murphy, B. R., & Collins, P. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1089-1099.2002 · Cited by 87
Tang, R. S., MacPhail, M., Schickli, J. H., Kaur, J., Robinson, C. L., Lawlor, H. A., Guzzetta, J. M., Spaete, R. R., & Haller, A. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11198-11207.2004 · Cited by 87
Genome-based approaches to develop vaccines against bacterial pathogens
Serruto, D., Serino, L., Masignani, V., & Pizza, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.072 · Cited by 86
Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis
Low, N. N., Kraemer, S., Schneider, M., & Restrepo, A. M. H. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.010 · Cited by 83
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants
Clark, H. F., Offit, P. A., Plotkin, S. A., & Heaton, P. M. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000220283.58039.b6 · Cited by 83
Self-citationBukreyev, A. A., Marzi, A., Feldmann, F., Zhang, L., Yang, L., Ward, J. M., Dorward, D. W., Pickles, R. J., Murphy, B. R., Feldmann, H., et al. (2008) · Virology · doi:10.1016/j.virol.2008.09.030 · Cited by 76
Ehrenfeld, E., Modlin, J. F., & Chumakov, K. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.49 · Cited by 74
Fraillery, D., Baud, D., Pang, S., Schiller, J. T., Bobst, M., Zosso, N., Ponci, F., & Nardelli‐Haefliger, D. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00164-07 · Cited by 68
The prime-boost concept applied to HIV preventive vaccines.
Jl, E., & Plotkin, S. A. (1997) · PubMed · Cited by 67
Self-citationDelivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann, J. F. S., Acevedo, R., del Campo, J. M., Pérez, O., & Ferro, V. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.8.1.103 · Cited by 66
Jones, B. G., Zhan, X., Mishin, V. P., Slobod, K. S., Surman, S. L., Russell, C. J., Portner, A., & Hurwitz, J. L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.041 · Cited by 58
Ljungberg, K., Whitmore, A. C., Fluet, M. E., Moran, T. P., Shabman, R. S., Collier, M., Kraus, A., Thompson, J. M., Montefiori, D. C., Beard, C. W., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01799-07 · Cited by 58
Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects
Radošević, K., Rodríguez, A., Lemckert, A. A. C., & Goudsmit, J. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.14 · Cited by 58
Ben‐Yehuda, A., Joseph, A., Barenholz, Y., Zeira, E., Even‐Chen, S., Louria‐Hayon, I., Babai, I., Zakay‐Rones, Z., Greenbaum, E., Galprin, I., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00251-2 · Cited by 57
Current Status of Group A Streptococcal Vaccine Development
Dale, J. B. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73960-1_5 · Cited by 54
McMurry, J. A., Johansson, B. E., & Groot, A. S. D. (2008) · Human Vaccines · doi:10.4161/hv.4.2.5169 · Cited by 44
Genome‑based vaccine development: A short cut for the future
Moriel, D. G., Scarselli, M., Serino, L., Mora, M., Rappuoli, R., & Masignani, V. (2008) · Human Vaccines · doi:10.4161/hv.4.3.6313 · Cited by 43
KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity
Škoberne, M., Yewdall, A. W., Bahjat, K. S., Godefroy, E., Lauer, P., Lemmens, E. E., Liu, W., Luckett, W. S., Leong, M. L. L., Dubensky, T. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31350 · Cited by 39
DNA Shuffling and Screening Strategies for Improving Vaccine Efficacy
Locher, C. P., Paidhungat, M., Whalen, R. G., & Punnonen, J. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.256 · Cited by 36
The Impact of a Boosting Immunogen on the Differentiation of Secondary Memory CD8 + T Cells
Hovav, A., Panas, M. W., Osuna, C. E., Cayabyab, M. J., Autissier, P., & Letvin, N. L. (2007) · Journal of Virology · doi:10.1128/jvi.01519-07 · Cited by 30
García‐Piñeres, A., Hildesheim, A., Dodd, L. E., Kemp, T. J., Yang, J., Fullmer, B. A., Harro, C. D., Lowy, D. R., Lempicki, R. A., & Pinto, L. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1706 · Cited by 29
An overview of animal cell substrates for biological products
Petricciani, J. C., & Sheets, R. (2008) · Biologicals · doi:10.1016/j.biologicals.2008.06.004 · Cited by 28
Proteomic technology in the design of new effective antibacterial vaccines
Jagusztyn-Krynicka, E. K., Dadlez, M., Grabowska, A. D., & Roszczenko, P. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.47 · Cited by 21
Attenuation by a Thousand Cuts
Coffin, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmcibr0805820 · Cited by 15
Human immunodeficiency virus vaccines
Girard, M. P., & Koff, W. C. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50054-4 · Cited by 9
Robinson, H. L. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-1000 · Cited by 5
Formulations and Delivery Systems for Mucosal Vaccines
Malyala, P., & Singh, M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8412-6_19 · Cited by 2
Bianchi, E., Ingallinella, P., Finotto, M., Joyce, J. G., Liang, X., Miller, M. D., Kinney, G. G., Ciliberto, G., Shiver, J. W., & Pessi, A. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73657-0_54 · Cited by 2
Cited by
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Toth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 464
Current state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
The development of vaccines: how the past led to the future
Plotkin, S. A., & Plotkin, S. L. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2668 · Cited by 333
Self-citation
Metadata
- Authors
- Plotkin, S. A.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2009-12
- Volume
- 16
- Issue
- 12
- Pages
- 1709-1719
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2122718880
- Cited by
- 256
- References
- 98
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.